Download Files:
Rilotumumab
Price range: 408 CAD through 4,608 CAD
Products Details
Product Description
– Rilotumumab (AMG 102) is a monoclonal antibody targeting hepatocyte growth factor that inhibits HGF/ MET-driven signaling. Rilotumumab has antitumor effects and can be used to study castration-resistant prostate cancer (CRPC) and gastric cancer.
Web ID
– T76758
Storage Temperature
– -20℃
Shipping
– Blue Ice
References
– Ryan CJ, et al. Targeted MET inhibition in castration-resistant prostate cancer: a randomized phase II study and biomarker analysis with rilotumumab plus mitoxantrone and prednisone. Clin Cancer Res. 2013 Jan 1;19(1):215-24.
CAS Number
– 872514-65-3
Molecular Weight
Compound Purity
– 97.51% (SEC-HPLC)
Pathway
– Tyrosine Kinase/Adaptors
Product type
– Inhibitory Antibodies
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
Related Products
1000 in stock
1000 in stock
